Generate Biomedicines plans up to $425 million U.S. IPO
Go back to Generate Biomedicines plans up to $425 million U.S. IPO| (NASDAQ: GENB) | Delayed: 15.72 +0.33 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.39 | 52 Week High | $ | |||
| Open | $15.44 | 52 Week Low | $ | |||
| Day High | $15.88 | P/E | N/A | |||
| Day Low | $15.32 | EPS | $ | |||
| Volume | 666,177 | |||||

